These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33590949)

  • 61. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA.
    Offer H; Erez N; Zurer I; Tang X; Milyavsky M; Goldfinger N; Rotter V
    Carcinogenesis; 2002 Jun; 23(6):1025-32. PubMed ID: 12082025
    [TBL] [Abstract][Full Text] [Related]  

  • 62. p53-dependent cell cycle control: response to genotoxic stress.
    Schwartz D; Rotter V
    Semin Cancer Biol; 1998; 8(5):325-36. PubMed ID: 10101798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of DNA damage responses in p53 biology.
    Speidel D
    Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response.
    López-Díaz FJ; Gascard P; Balakrishnan SK; Zhao J; Del Rincon SV; Spruck C; Tlsty TD; Emerson BM
    Mol Cell; 2013 May; 50(4):552-64. PubMed ID: 23706820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.
    Otsuka K; Ochiya T
    Biomed Res Int; 2014; 2014():749724. PubMed ID: 25302307
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision.
    Sun CY; Zhang XP; Wang W
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.
    Stommel JM; Wahl GM
    Cell Cycle; 2005 Mar; 4(3):411-7. PubMed ID: 15684615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.
    Kiran S; Oddi V; Ramakrishna G
    Exp Cell Res; 2015 Feb; 331(1):123-141. PubMed ID: 25445786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity.
    Rizzotto D; Englmaier L; Villunger A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639222
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The tumour suppressor CYLD regulates the p53 DNA damage response.
    Fernández-Majada V; Welz PS; Ermolaeva MA; Schell M; Adam A; Dietlein F; Komander D; Büttner R; Thomas RK; Schumacher B; Pasparakis M
    Nat Commun; 2016 Aug; 7():12508. PubMed ID: 27561390
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.
    Ludwig RL; Bates S; Vousden KH
    Mol Cell Biol; 1996 Sep; 16(9):4952-60. PubMed ID: 8756654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.
    Li Y; Liu J; McLaughlin N; Bachvarov D; Saifudeen Z; El-Dahr SS
    Physiol Genomics; 2013 Oct; 45(20):948-64. PubMed ID: 24003036
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor suppressor p53 is required to modulate BRCA1 expression.
    Arizti P; Fang L; Park I; Yin Y; Solomon E; Ouchi T; Aaronson SA; Lee SW
    Mol Cell Biol; 2000 Oct; 20(20):7450-9. PubMed ID: 11003642
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress.
    Chang J; Davis-Dusenbery BN; Kashima R; Jiang X; Marathe N; Sessa R; Louie J; Gu W; Lagna G; Hata A
    EMBO J; 2013 Dec; 32(24):3192-205. PubMed ID: 24219989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dynamic analysis of the combinatorial regulation involving transcription factors and microRNAs in cell fate decisions.
    Yan F; Liu H; Liu Z
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):248-57. PubMed ID: 23845991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.